VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 142 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,358 | -88.9% | 57,490 | -66.2% | 0.00% | -90.9% |
| Q4 2020 | $2,234,000 | -24.7% | 170,000 | -23.9% | 0.01% | -38.9% |
| Q3 2019 | $2,966,000 | +56.1% | 223,375 | +78.7% | 0.02% | +125.0% |
| Q4 2017 | $1,900,000 | +6.1% | 125,000 | +25.0% | 0.01% | 0.0% |
| Q3 2017 | $1,790,000 | -94.3% | 100,000 | -94.9% | 0.01% | -95.5% |
| Q2 2017 | $31,661,000 | -9.0% | 1,942,400 | -21.8% | 0.18% | -8.2% |
| Q1 2017 | $34,783,000 | +1343.3% | 2,484,500 | +1544.3% | 0.19% | +1041.2% |
| Q4 2016 | $2,410,000 | -73.3% | 151,100 | -72.2% | 0.02% | -73.4% |
| Q3 2016 | $9,031,000 | +42904.8% | 542,700 | +28463.2% | 0.06% | – |
| Q3 2015 | $21,000 | -98.3% | 1,900 | -98.0% | 0.00% | -100.0% |
| Q2 2015 | $1,225,000 | – | 96,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |